B440
YASHIN ET AL.
Acknowledgments
longer and aged slower (by a number of physiological pa-
rameters). At the same time, they are frailer at their young
and adult ages, and they are more robust at old ages than ro-
dents in the control group. Furthermore, in populations with
lower survival earlier in life and higher survival later in life,
tumorigenesis is going slower (32). This observation is ex-
pected in the population of labile individuals, in which the
accumulation of damage associated with the excess of meta-
bolic activity is slower than in the stable individuals. A sim-
ilar antagonistic change of survival in adult and in old ages
was observed in some experiments on rodents exposed to
caloric restriction, a treatment known to increase longevity
and postpone aging (35).
This research was partly supported by National Institutes of Health/Na-
tional Institute on Aging Grant 7P01AG08761-09 and by Russian Fund of
Basic Research Grant 99-01-00185. The authors thank James W. Vaupel
for the opportunity to use facilities of the Max Planck Institute for Demo-
graphic Research in Rostock, Germany, during this study, and Baerbel
Splettstoesser and Karl Brehmer for help in preparing this paper for publi-
cation. Dr. Yashin is now also affiliated with the Sanford Institute for Pub-
lic Policy, Duke University, Durham, NC.
Address correspondence to Anatoli Yashin, Max Planck Institute for
Demographic Research, Doberaner Strasse 114, 18057 Rostock, Germany.
E-mail: yashin@demogr.mpg.de
References
Experimental studies show that labile and stable pheno-
types may be the result of gene–environment interactions
(36). It means that individuals who are stable in one set of
environmental conditions may manifest a labile phenotype
in case of another set of conditions and vice versa. In any
case, all the above data agree with the existence of labile
and stable individuals assumed in our model.
1. Vaupel J, Carey J, Christensen K, et al. Biodemographic trajectories of
longevity. Science. 1998;280:855–860.
2. Fries JF. Aging, natural death and the compression of morbidity. N
Engl J Med. 1980;303(3):130–135.
3. Fries JF. Compression of morbidity of the elderly. Vaccine. 2000;
18(16):1584–1589.
4. Vaupel JW, Jeune B. The emergence and proliferation of centenarians.
In: Jeune B, Vaupel JW, eds. Experimental Longevity: from Prehistory
to the Present. Odense, Denmark: Odense University Press; 1995:
109–116.
Evolutionary Adaptation May Produce an Intersection
of Mortality Curves
5. Myers GC, Manton KG. Compression of mortality: myth or reality?
Gerontol. 1984;24(4):346–359.
The intersection of survival curves may have evolution-
ary reasons. The evolutionary theories suggest that genes
that would enhance fitness earlier in life may be selected
for, even if they produce detrimental effects later in life
(37). Because the notion of fitness involves fertility as well
as mortality, one may assume that mortality rates for geno-
types may have a spectrum of possible shapes (the average
fertility rates for the populations of these genotypes must
also be different). These theories link the life span with the
quality of maintenance and repair systems in the cells of an
organism. However, they do not provide an explicit descrip-
tion of possible mechanisms, which relate characteristics of
physiological and biological aging with demographic sur-
vival curves. The idea of disposable soma suggested by
Kirkwood (38) looks promising; however, it requires addi-
tional specification of resource-allocation strategies that
may depend on environmental conditions. In addition, none
of the theories explains why some individuals in a popula-
tion are more sensitive to industrial progress than the others.
6. Manton KG, Tolley HD. Rectangularization of the survival curve: im-
plications of an ill-posed question. J Aging Health. 1991;3(2):172–
193.
7. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pa-
thology. In: Fisher S, Reason J, eds. Handbook of Life Stress,
Cognition and Health. New York: Wiley; 1988:629–649.
8. De Benedictis G, Carotenuto L, Carrieri G, De Luca M, Falcone E,
Rose G, Cavalcanti S, Corsonello F, Feraco E, Baggio G, Bertolini S,
Mari D, Mattace R, Yashin AI, Bonafè M, Franceschi C. Gene/longev-
ity association studies at four autosomal loci (REN, THO, PARP,
SOD2). Eur J Hum Genet. 1998;6:534–541.
9. De Benedictis G, Carotenuto L, Carrieri G, De Luca M, Falcone E,
Rose G, Yashin AI, Bonafe M, Franceschi C. Age-related changes of
the 3ꢃ APOB VNTR genotype pool in ageing cohorts. Ann Hum Genet.
1998;62:115–122.
10. Altukhov YP, Sheremetjeva VA. Genomic heterozygosity and human
longevity. Doklady Biol Sci. 2000;371:197–199.
11. Fogel RW, Costa DL. A theory of technophysio evolution, with some
implications for forecasting population, health care costs and pension
costs. Demography. 1997;(34)1:49–66.
12. Ukraintseva SV. Evolution of morbidity in human history. Clin Geron.
1998;4:61–65.
13. Robine JM, Forette C, Franceschi C. The Paradoxes of Longevity.
New York: Springer-Verlag; 1999.
14. Faure-Delanef L, Quere I, Zouali H, Cohen D. Human longevity and
R506Q factor V gene mutation. Thromb Haemost. 1997;78(3):1160.
15. Harman D. The aging process. Proc Natl Acad Sci USA. 1981;78(11):
7124–7128.
16. Brattstromm L, Zhang Y, Hurtig M, et al. A common methylenetet-
rahydrofolate reductase gene mutation and longevity. Atherosclerosis.
1998;1412:315–319.
17. Bladbjerg EM, Andersen-Ranberg K, de Maat MP, et al. Longevity is
independent of common variations in genes associated with cardiovas-
cular risk. Thromb Haemost. 1999;82:1100–1105.
18. Schächter, F. Causes, effects, and constraints in the genetics of human
longevity. Am J Hum Genet. 1998;62(5):1008–1014.
19. Galinsky D, Tysoe C, Bryne C, et al. Analysis of the ApoE/ApoC-1,
ACE genes as candidates affecting human longevity. Atherosclerosis.
1997;129:(2)177–183.
20. Mannucci PM, Mari D, Merati G, et al. Gene polymorphisms predict-
ing high plasma levels of coagulation and fibrinolysis proteins. A
study in centenarians. Arterioscler Thromb Vasc Biol. April 1997;17:
4, 755.
Conclusions
Mortality decline in the human population forms a sur-
vival pattern, which shows signs of both the rectangulariza-
tion of the survival curve and the lengthening of the tails of
survival distributions (5,39,40). In this paper we propose a
mixed stochastic–deterministic mathematical model of sur-
vival, which incorporates parameters directly related to
qualitative features such as adaptive capacity and sensitivity
to environmental changes of an individual. The qualitative
analysis and the simulation experiments show that the ob-
served pattern of mortality as well as trends in human sur-
vival can be explained in terms of a mixture of two subpop-
ulations. An important feature of these subpopulations is
that their mortality rates intersect, thus giving a solid inter-
pretation to the intersection of mortality curves often ob-
served in the studies of aging and survival, including human
and nonhuman subjects.
21. Pepe G, Di Perna V, Resta F. In search of a biological pattern for human
longevity: Impact of apo A-IV genetic polymorphisms on lipoproteins